Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic Encephalopathy.

Srinivasan Dasarathy1, Kevin D. Mullen

  • 1Gastrointestinal Division, Department of Medicine, MetroHealth Medical Center, 2500 MetroHealth Drive, Bell Greve Building, Cleveland, OH 44109-1998, USA. kmullen@metrohealth.org

Current Treatment Options in Gastroenterology
|November 7, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and Mediators.

Bioinformatics (Oxford, England)·2026
Same author

Urine Proteomic Profiling at Admission Reveals Complement Biomarkers Linked to Alcohol-Associated Liver Disease.

Alcohol, clinical & experimental research·2026
Same author

The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease.

Nature communications·2026
Same author

Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease with elevated aminotransferases: A multicenter, randomized, placebo-controlled trial.

Hepatology (Baltimore, Md.)·2026
Same author

Mean Arterial Pressure at Admission Predicts 28-day Mortality in Patients with Severe Alcohol-associated Hepatitis.

Clinical and translational gastroenterology·2026
Same author

SIRPα Cleavage Is Associated with Inflammatory Response, Corticosteroid Nonresponse, and Worse Prognosis in Clinical and Preclinical Models of Alcohol-Associated Hepatitis.

The American journal of pathology·2026
Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025
Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023
Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023
Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023
Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023
Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023
See all related articles

Hepatic encephalopathy (HE) management focuses on supportive care, ruling out other causes, correcting triggers, and reducing ammonia levels. Most patients with chronic liver disease can fully recover with appropriate treatment.

Area of Science:

  • Hepatology
  • Neuroscience
  • Gastroenterology

Background:

  • Hepatic encephalopathy (HE) presents with neuropsychiatric changes.
  • A key feature of HE is the potential for complete patient recovery.
  • This review focuses on HE in individuals with chronic liver disease.

Purpose of the Study:

  • To outline the optimal management strategy for hepatic encephalopathy (HE).
  • To detail essential therapeutic elements for HE patients with chronic liver disease.

Main Methods:

  • Review of standard supportive therapy for altered mental status.
  • Emphasis on ruling out or controlling concomitant causes of encephalopathy.
  • Identification and correction of precipitating factors.
  • Implementation of gut-cleansing and ammonia-lowering measures.

Related Experiment Videos

Main Results:

  • Standard supportive care is the mainstay for altered mental status.
  • Excluding other causes is crucial for accurate HE diagnosis.
  • Addressing precipitating factors is a key management step.
  • Ammonia-lowering strategies target putative encephalogenic toxins.

Conclusions:

  • Optimal HE management integrates supportive care, etiological investigation, trigger identification, and detoxification.
  • Prompt and comprehensive management improves recovery outcomes in HE patients.
  • Targeting ammonia is central to neutralizing neurotoxins in HE.